Lucintel Forecasts The Global Fibromuscular Dysplasia Treatment Market Is Expected To Grow With A Cagr Of 7.3% From 2024 To 2030

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to a market report by Lucintel, the future of the global fibromuscular dysplasia treatment market looks promising with opportunities in the hospitals pharmacies, retail pharmacies, and online pharmacies markets. The global fibromuscular dysplasia treatment market is expected to grow with a CAGR of 7.3% from 2024 to 2030. The major drivers for this market are increasing incidence of hypertension across the global population and rising occurrence of smoking.
A more than 150–page report is developed to understand Trends, opportunity and forecast in fibromuscular dysplasia treatment market to 2030 by drug class (angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, diuretics, calcium channel blockers, beta-blockers, and others), distribution channel (hospitals pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers, diuretics, calcium channel blockers, and beta-blockers are the major segments of fibromuscular dysplasia ...
... treatment market by drug class. Lucintel forecasts that angiotensin II receptor blockers is expected to witness the highest growth over the forecast period.
Within this market, hospitals pharmacies will remain the largest segment.
Download sample by clicking on fibromuscular dysplasia treatment market
North America is expected to witness highest growth over the forecast period.
ALVOGEN, Aspen Surgical Products, AstraZeneca, B. Braun Melsungen, Bayer Healthcare Pharmaceuticals, Becton, Dickinson & Company, Pfizer, Sanofi-Aventis, and Smith & Nephew are the major suppliers in the fibromuscular dysplasia treatment market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
Power Optimizer Market in Canada
Secondary Water & Wastewater Treatment Equipment Market in Canada
Semiconductor Cooling Module Market in Canada
Speech Biomarker Market in Canada
Stretchable Conductive Ink Market in Canada